Read Jamie Madrigal, Dougald Monroe, Suzanne Sindi and Karin Leiderman’s Latest Analysis on Emicizumab
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions
This study used mathematical modeling and biochemical assays to dissect how emicizumab, a bispecific antibody bridging activated factor IXa and factor X, functions differently from factor VIII.
It revealed that high emicizumab levels inhibit factor X activation via tissue factor pathway due to reduced lipid surface binding but enhance factor IXa-dependent activation of factor X on lipid surfaces.
The model provides kinetic estimates and explains emicizumab’s mechanism of enhancing coagulation through lipid-surface interactions.
Read this paper.
Authors: Jamie Madrigal, Dougald Monroe, Suzanne Sindi, Karin Leiderman”
Read the full article in JTH.
Article: Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions
Authors: Jamie Madrigal, Dougald Monroe, Suzanne Sindi, Karin Leiderman
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 4, 2025, 10:26Gaetan Duport about HTA and Reimbursement Models in Treatments for Bleeding Disorders
-
Oct 3, 2025, 16:31Ronit Kar and Team Used Microfluidic Technology and Found That Platelets From Pediatric Trauma
-
Oct 3, 2025, 07:53Pancytopenia in Pregnancy: A Time-Critical Hematological Emergency
-
Oct 2, 2025, 14:12Helen McPherson at ISFP-IFRS 2025: Fibrin Clot Structure and Function Modulation by Targeting Fibrinogen aC Region
-
Oct 2, 2025, 10:48Kanishk Kumar: TFPI Market Size - Advancing Hemostasis and Antithrombotic Therapy
-
Oct 4, 2025, 10:23Read Jamie Madrigal, Dougald Monroe, Suzanne Sindi and Karin Leiderman's Latest Analysis on Emicizumab
-
Oct 4, 2025, 10:19Alexandre Kauskot Thanks Marie A Hollenhorst on Her Editorial On His Recent Publication on Platelet Glycotime
-
Oct 4, 2025, 10:10Alessio Branchini Shares His Latest Work on Albumin-Fused Factor IX Variants and Thanks The Whole Team
-
Oct 3, 2025, 16:37Steven Murphy Highlights New Research Linking POTS Platelets to Storage Pool Deficiency
-
Oct 3, 2025, 16:33Roberta Gualtierotti and Jacopo Acquati Lozej Will Explore Strategies to Preserve Joint Health
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 1, 2025, 15:59Anirban Sen Gupta: Thrilled to share a great collaboration story in Nature Portfolio
-
Oct 4, 2025, 10:21Maria Elisa Mancuso: Chance to Listen to Inspiring Experiences of People Who Live With Bleeding Disorders
-
Oct 4, 2025, 10:04Stéphanie Roullet Gave Talk on Platelet-Inspired Nanoparticles at SFTH 2025 Congress
-
Oct 4, 2025, 09:55NBDF: Proud to See Our Own Teri F Willey Representing the Foundation in the Funding Rare Disease Research Webinar
-
Oct 4, 2025, 09:49Emmanuel J Favaloro: Promoting World Thrombosis Day Whilst Giving a Talk in Tasmania
-
Oct 3, 2025, 14:48Maha Othman - Elected as the Co-Lead for the Basic and Translational Research Platform at CanVECTOR Research Network